Lyukang ® (Tandospirone Citrate Capsules)

  • Product name: Lyukang ®
  • Pharmacology category: 5-HT1A receptor part agonist
  • Generic name: Tandospirone Citrate Capsules
  • National exclusive, and class B product of national medical insurance

Indication indication

Instructional indications

Various anxiety states caused by neuroses, like generalized anxiety disorder;

Anxiety state accompanied by primary hypertension, peptic ulcer, and physical diseases.

Product advantage

Product Advantage
  • Double action mechanism

    5-HT1A receptor part agonist (antianxiety + depressurization)

  • High safety

    Not cause suicide, obesity and sexual dysfunction

  • Wide selectivity

    Multidepartment medication, to facilitate the clinical prescription selection

  • Not limited by prescription

    Non-psychotropic management drug

  • FDA certification

    Pass American FDA certification in production quality management system; bioequivalence as the originally researched product

  • Unique indications

    Unique antianxiety drug with digestion and heart disease accompanied with anxiety

  • Optimal choice

    No withdrawal reaction, the basic drug for psychosomatic diseases

Core patent

Core patent

Many national invention patents have been obtained.

  • Preparation
  • Tandospirone
  • Pharmaceutical preparation
  • Combination
  • Packing box
  • Cognitive function
  • Headache
  • Method
  • Insomnia
  • Consensus of guidelines

    It is recommended by many guides that Tandospirone can be widely applied in the treatment of patients with psychiatry, neurology, cardiology and digestion system diseases accompanied with anxiety and it can help to improve the physical symptoms and psychiatric symptoms of patients at the same time.
  • clinical application

    Clinical application

    Lyukang®, as a new 5-HT1A receptor part agonist

    is the 3rd-generation new antianxiety drug

    and it has been widely applied in clinical departments of mind, neurology, cardiology and digestion in more than 2,000 large and medium-sized hospitals throughout the country.

Clinical application of Department

Clinical application of Department
  • Psychiatry: Increase, Make a Difference

    1. Treatment of generalized anxiety disorder: Lukang (10-20 mg, tid) alone or combined with benzodiazepines can quickly control anxiety symptoms.
    2. Synergistic treatment of psychiatric diseases:
    (1) Treatment of depression: Lukang (10mg, tid) + antidepressants can enhance the efficacy and improve the sexual dysfunction caused by antidepressants;
    (2) Treatment of schizophrenia: Lukang (10mg, tid) plus antipsychotics can enhance the efficacy and improve the cognitive and memory function of patients. Clinical studies and meta-analysis at home and abroad have confirmed the clinical application of tandorone in improving anxiety and enhancing the efficacy of antidepressants and antipsychotics.

  • Psychiatry: Target-specific, direct-to-anxiety

    1. Generalized anxiety disorder: Lukang (10mg, tid) alone or combined with benzodiazepines can quickly control anxiety symptoms.
    2. Neurological diseases with anxiety: Lukang (10mg, tid) +routine treatment can improve anxiety and physical symptoms of patients; domestic and foreign studies have shown that Lukang can rapidly improve anxiety symptoms and quality of life of patients with generalized anxiety disorder, for common neurological diseases (such as stroke, Parkinson's disease, epilepsy, hypertension). And primary headache, etc.) accompanied by anxiety has a definite effect.

  • Pain Department

    1. Generalized anxiety disorder: Lukang (10mg, tid) alone or combined with benzodiazepines can quickly control anxiety symptoms;
    2. Mild hypertension patients: single use of Lukang (10mg, tid) or combined use of antihypertensive drugs, at the same time to reduce blood pressure and alleviate anxiety in patients.
    3. Cardiovascular diseases with anxiety: Lukang (10mg, tid)+routine treatment can effectively control the cardiovascular system function changes caused by mental stress, especially for patients with hypertension caused by mental and psychological factors (M-type hypertension), coronary heart disease, myocardial ischemia and other associated anxiety.
    The only anti-anxiety drug with hypertension and anxiety indications!

Scope of solicitation:

1. Linguan Zhengwen

Lukang combined with antidepressants in the treatment of depression can enhance the efficacy of antidepressants and improve the sexual dysfunction caused by antidepressants.

Lukang combined with antipsychotic drugs for schizophrenia can enhance the efficacy of antipsychotic drugs and improve cognitive function.

Requirements for articles:

The article focuses on the clinical application of research, the number of cases is not less than 60 cases, the source of cases is real and reliable.

The article should be scientific and practical, with theoretical or practical significance, refined and smooth writing, accurate data and measurement units. All international standards shall be adopted.

The title does not exceed 20 words, and the text, together with charts, abstracts and references, generally does not exceed 6000 words. The Abstract includes the purpose, method, result and conclusion.

Generally no more than 200 words, 3-5 keywords need to be indexed.

Articles not published in publicly published journals and other academic exchanges.

Please indicate the author's name, unit, title, address, zip code and telephone number.

Submission method:

1) Requirements for submission of articles: Send the document name "Academic Essay + Doctor's Name + Contact Information" to the mailbox:lklunwen@163.com

2) The deadline for submission is 31 October 2018

Scope of solicitation:

1. Linguan Zhengwen

Lukang combined with antidepressants in the treatment of depression can enhance the efficacy of antidepressants and improve the sexual dysfunction caused by antidepressants.

Lukang combined with antipsychotic drugs for schizophrenia can enhance the efficacy of antipsychotic drugs and improve cognitive function.

Requirements for articles:

The article focuses on the clinical application of research, the number of cases is not less than 60 cases, the source of cases is real and reliable.

The article should be scientific and practical, with theoretical or practical significance, refined and smooth writing, accurate data and measurement units. All international standards shall be adopted.

The title does not exceed 20 words, and the text, together with charts, abstracts and references, generally does not exceed 6000 words. The Abstract includes the purpose, method, result and conclusion.

Generally no more than 200 words, 3-5 keywords need to be indexed.

Articles not published in publicly published journals and other academic exchanges.

Please indicate the author's name, unit, title, address, zip code and telephone number.

Submission method:

1) Requirements for submission of articles: Send the document name "Academic Essay + Doctor's Name + Contact Information" to the mailbox:lklunwen@163.com

2) The deadline for submission is 31 October 2018